FactSet Still Offers More Than 30% Upside

FactSet (FDS) is viewed as undervalued at 13.6x earnings and 15.8x FCF versus long-term averages. In Q3, it posted 7.0% organic revenue growth and 6.1% adjusted EPS growth, while margins faced pressure from growth initiatives. Management reaffirmed FY26 guidance, citing a margin-improvement path via AI-driven workflow enhancements and accelerated share buybacks.

Analysis

FDS looks more like a self-help compounder than a pure growth story: the market is still pricing the business as if margin pressure is permanent, while the underlying franchise is continuing to compound at a mid-single to high-single-digit rate. The key mechanism is not just revenue growth, but operating leverage from product automation plus buybacks; if that shows up in reported margins over the next 2-4 quarters, earnings can outrun revenue and force a multiple reset.

Second-order, AI is likely defensive before it is offensive. If workflow enhancements reduce analyst-hours per account, FDS can protect renewal rates and defend against share loss to Bloomberg, MSCI, SPGI, and LSEG rather than instantly monetizing AI as a new revenue line. The bear case is that customers demand some of those productivity gains back in pricing, which would delay margin expansion even if the product gets better.

The setup is best viewed over 1-3 months as a "prove-it" trade and over 6-18 months as a valuation re-rating if margins inflect. The immediate catalyst is guidance credibility plus capital return cadence; the thesis weakens if organic growth decelerates below mid-single digits or if buybacks merely offset dilution without shrinking the share count meaningfully. Consensus may be missing that a low-teens multiple for a sticky data/analytics franchise is hard to justify if EPS can compound high-single digits with limited balance-sheet risk.

Key Decisions for Investors

• Initiate a starter long in FDS on any post-earnings or market-wide pullback; target a 6-12 month re-rating from low-teens earnings multiples toward the mid-to-high teens if margin progression is visible. Risk/reward is attractive if downside is capped by recurring revenue and buyback support.
• Pair trade: long FDS / short MSCI or SPGI as a relative-value expression of undervalued recurring data revenue versus premium-valued peers. This works best if the next two quarters confirm margin expansion without sacrificing growth; cover if FDS growth slips below peers or AI spend reaccelerates.
• For option exposure, consider a 6-9 month call spread on FDS rather than outright calls if you want leverage to a re-rating but want to limit theta while the market waits for proof of margin improvement.
• Set a falsifier: if FY26 guidance is reaffirmed but next two quarters fail to show sequential margin improvement, reduce exposure; the stock can stay cheap longer if AI investment is still being expensed ahead of benefit.
• Watch share count and FCF conversion closely over the next 2 reporting cycles; if buybacks start driving tangible EPS accretion, this becomes a cleaner long, but if cash deployment is more symbolic than accretive, the valuation case weakens.